Navigation Links
MannKind Reports Positive Results from Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
Date:12/4/2008

Pivotal efficacy and safety studies meet primary endpoints

VALENCIA, Calif., Dec. 4/PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD) today announced that it has met the primary endpoints of its final two pivotal Phase 3 studies of AFRESATM, the company's ultra rapid acting, inhaled insulin product. The company expects to disclose more details of the top-line data from these studies in patients with type 1 and type 2 diabetes (studies 030 and 102) by mid-December.

"We are very pleased to announce the positive outcome of these, the last of our three pivotal Phase 3 studies. We look forward to presenting more complete data, including analyses of secondary endpoints, as soon as they are available, which are expected before the end of this year. AFRESA promises to be an important additional option for the treatment of patients with diabetes. Our next step is to finalize a new drug application for AFRESA, which we expect to submit to the FDA in early 2009," commented Dr. Peter Richardson, MannKind's chief scientific officer.

About Study 030

Study 030 compared the pulmonary safety of meal-time inhalation of AFRESA versus usual care in over 2000 patients with type 1 and type 2 diabetes. The study met its primary endpoint: after two years of treatment, no adverse effects were observed on patients' lungs in the AFRESA-treated group.

About Study 102

Study 102 compared the efficacy of meal-time AFRESA in combination with a long-acting basal insulin versus twice daily injections of pre-mixed insulin (a mixture of a rapid-acting insulin analog and intermediate-acting insulin). Study 102 met its primary endpoint, showing comparable improvements in HbA1c levels over 52 weeks between the two treatment groups.

<
'/>"/>
SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MannKind Announces New $350 Million Credit Facility
2. MannKind to Present at Upcoming Conferences
3. MannKind Corporation Reports Third Quarter Financial Results
4. MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results
5. MannKind to Present at the Cowen and Company Healthcare Conference
6. The Leukemia & Lymphoma Society and MannKind Corporation Announce Collaborative Research Agreement
7. MannKind Corporation to Host Webcast Analyst Day September 16, 2008
8. MannKind Corporation Reports Third Quarter Financial Results
9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
10. Haemacure Reports Third Quarter 2007 Results
11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... New York, New York (PRWEB) September 17, 2014 ... ) filings involving the Conserve line of metal-on-metal ... litigation now underway in U.S. District Court, Northern ... to an updated Case List issued by the ... 15, 2014, at least 397 product liability claims ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 The Food ... today, September 17, 2014, to consider: , ... Therapy (TRT), and, 2. The potential ... , With the TRT litigation ongoing, an informally-organized litigation ... the dangers of testosterone replacement therapy. Among others, ZKB ...
(Date:9/17/2014)... StartX , a nonprofit technology accelerator ... of funding at its Summer Demo Day yesterday. The ... was the first such gathering held at StartX’s new, ... The presentations were delivered on an expansive stage built ... 2,000 square foot life science facility that opened last ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Cadiz ... treatments and cosmetic procedures to clients throughout Central ... of services is Collagen Induction Therapy. Using the ... are able to help clients correct a wide ... introduced this month, and Cadiz Laser Spa is ...
(Date:9/17/2014)... -- Present-day Europeans are the descendants of at ... a new study. Previous research suggested ... European farmers. But, a new genetic analysis involving ... descendants of Ancient North Eurasians. Nearly all present-day ... group, researchers from Harvard Medical School said. , ...
Breaking Medicine News(10 mins):Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 3Health News:FDA Advisory Committee Holds Hearing on Testosterone Safety 2Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 2Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 3Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 4Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 5Health News:Stanford-affiliated StartX Showcases Startups, New HQ, and Growth of Stanford-StartX Fund 6Health News:Revolutionary Collagen Induction Therapy is Now Available at Cadiz Laser Spa 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 3
... no health insurance don,t see a doctor all year ... children share at least one frightening fact: If they are ... health care... period. , New research from the University ... children in families earning between $38,000 and $77,000 annually who ...
... Universitys Slone Epidemiology Center have found that approximately one ... and cold medications during a given week. These ... Academic Societies & Asian Society for Pediatric Research Joint ... medications are widely marketed in the U.S. but surprisingly ...
... Two new studies conducted by researchers at Cincinnati Childrens ... parental job loss on childrens healthcare and the importance ... healthcare needs and reduce healthcare disparities. , The studies ... meeting of the Pediatric Academic Societies in Honolulu. , ...
... Calif., May 2 The following is,being issued ... protect,Kaiser facilities will launch an unfair labor practice ... Tuesday, May 6. This is the,first-ever group of ... and spied on workers who were trying to ...
... JUROR MISCONDUCT, LITTLE ROCK, Ark., May 2 ... suing Arkansas Children,s Hospital,over a wrong sided brain surgery ... "We have concerns about the accuracy of statements made ... has been a possibility of,juror misconduct," said attorney Phillip ...
... immunotherapy technique to help prevent the progression from ... simple, cost-effective technique are published May 2nd in ... an overwhelming need for effective immunotherapies for HIV, ... highly toxic. The authors, led by Professor ...
Cached Medicine News:Health News:Middle Class Uninsured Kids' Health Risk Almost as High as Poor Children's 2Health News:1 in 10 children using cough, cold medications 2Health News:US unemployment having impact on kids' health-care coverage -- and that puts their health at risk 2Health News:First-Ever Group of Hospital Security Officers to Strike over Unfair Labor Practices, Walk out of Facilities Across California on May 6 2Health News:Wrong-Sided Brain Surgery Trial Halted 2
(Date:9/17/2014)... Sept. 17, 2014 /PRNewswire-iReach/ -- ChemImage announced ... discussing improvements in the development of imaging ... both normal and diseased tissue that minimizes ... surgical procedures, lowers surgical costs and potentially ... The clinical and scientific ...
(Date:9/17/2014)... Minn. , Sept. 17, 2014 ACIST ... global market leader of advanced imaging modalities for cardiology, ... System in two live cases at the Transcatheter Cardiovascular ... The cases were presented from Medstar Washington Hospital Center ... Hospital/Columbia University Medical Center ( New York, NY ...
(Date:9/17/2014)... 17, 2014  Millions of people suffer from neck and ... Recently the FDA approved the launch of a ... implant device developed by Spinal Kinetics, which may offer relief ... or arm pain. Hospital for Special Surgery (HSS), the number ... in New York City and in ...
Breaking Medicine Technology:Patient Outcomes Improve When Molecular Chemical Imaging Technology Is Used to Aid Robotic Surgical Procedures, According to New White Paper 2ACIST Launches HDi High-Definition IVUS 2ACIST Launches HDi High-Definition IVUS 3Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery 2
... Fenwal, Inc., a global medical technology company focused on ... names of 16 inspiring individuals inducted into the company,s 2010 ... than a decade, Fenwal has partnered with blood centers to ... in assuring medicine,s most vital natural resource -- blood -- ...
... Systems (NYSE: VAR ) today announced the execution ... to supply medical imaging subcomponents to Toshiba Medical Systems for ... will be booked over the period of the agreement. ... it marks the latest chapter in our 30+ year relationship ...
Cached Medicine Technology:2010 Inductees to the Fenwal Blood Donation Hall of Fame 22010 Inductees to the Fenwal Blood Donation Hall of Fame 3Varian Medical Systems Announces X-Ray Products Contract With Toshiba Medical Systems 2
ENDOlap™ laparoscopes provide excellent image linearity and flatness of field....
Inquire...
The Fujinon's R410 laparoscope is the first to bring a 410,000 pixel CCD to the end of the scope. Superior imaging and color replication, along with a unique lens washing capability make the R410 the...
ACMI™ Distortion-Free Laparoscopes utilize technical advances in optical lens design to provide images without the fish-eye effect typically found on the peripheral viewing edges of conventional...
Medicine Products: